HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exposure of cultured primary rat astrocytes to hypoxia results in intracellular glucose depletion and induction of glycolytic enzymes.

Abstract
Based on the neurotrophic properties of astrocytes in response to ischemia, the current work focuses on the mechanism for cultured astrocytes to adapt to a hypoxic environment. Intracellular glucose levels in primary cultured rat astrocytes exposed to hypoxia fell by 30% within 24 h, in parallel with a decrease in glycogen stores. Glycolytic metabolism was crucial for cell survival during hypoxia, as 2-deoxyglucose resulted in rapid ATP depletion and cell death. The mechanism for maintaining glucose levels under these conditions appeared to be mobilization of glycogen stores, rather than increased extracellular uptake of glucose, as gluconolactone (an inhibitor of beta1-4 amyloglucosidase) induced a rapid fall in cellular ATP in cultures subjected to hypoxia, whereas cytochalasin B was without affect. Addition of cycloheximide diminished the viability of astrocytes in hypoxia, suggesting an obligatory role of de-novo gene expression to respond to hypoxia. Consistently, the results of differential display suggested the induction of glycolytic enzymes, including aldolase A (EC 4.1.2.13), hexokinase II (ATP: D-hexose 6-phosphotransferase, EC 2.7.1.1), and triosephosphate isomerase (EC 5.3.1.1) in the hypoxic culture. Marked induction of these glycolytic enzymes in hypoxic astrocytes was confirmed by Northern blot analysis. These data provide a theoretical basis to understand the ability of astrocytes to tolerate ischemic condition.
AuthorsY Niitsu, O Hori, A Yamaguchi, Y Bando, K Ozawa, M Tamatani, S Ogawa, M Tohyama
JournalBrain research. Molecular brain research (Brain Res Mol Brain Res) Vol. 74 Issue 1-2 Pg. 26-34 (Dec 10 1999) ISSN: 0169-328X [Print] Netherlands
PMID10640673 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antimetabolites
  • DNA, Complementary
  • Enzymes
  • Protein Synthesis Inhibitors
  • RNA
  • Glycogen
  • Cycloheximide
  • Deoxyglucose
  • Hexokinase
  • Fructose-Bisphosphate Aldolase
  • Triose-Phosphate Isomerase
  • Glucose
  • Oxygen
Topics
  • Animals
  • Animals, Newborn
  • Antimetabolites (pharmacology)
  • Astrocytes (cytology, enzymology, metabolism)
  • Blotting, Northern
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Cycloheximide (pharmacology)
  • DNA, Complementary (genetics, isolation & purification)
  • Deoxyglucose (pharmacology)
  • Enzyme Induction
  • Enzymes (genetics, metabolism)
  • Fructose-Bisphosphate Aldolase (genetics, metabolism)
  • Gene Expression Regulation
  • Glucose (metabolism, pharmacokinetics)
  • Glycogen (metabolism)
  • Glycolysis
  • Hexokinase (genetics, metabolism)
  • Hypoxia (physiopathology)
  • Oxygen (pharmacology)
  • Protein Synthesis Inhibitors (pharmacology)
  • RNA (genetics, metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Triose-Phosphate Isomerase (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: